281
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Association between biomarkers of tobacco consumption and lung cancer risk among daily smokers

ORCID Icon, ORCID Icon, , , , ORCID Icon, , , ORCID Icon & ORCID Icon show all
Pages 247-252 | Received 23 Oct 2020, Accepted 11 Oct 2021, Published online: 25 Oct 2021

References

  • Ridge CA, McErlean AM, Ginsberg MS. Epidemiology of lung cancer. Semin Intervent Radiol. 2013;30(02):93–98.
  • Parsons A, Daley A, Begh R, et al. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ. 2010;340(jan21 1):b5569.
  • Oudkerk M, Devaraj A, Vliegenthart R, et al. European position statement on lung cancer screening. Lancet Oncol. 2017;18(12):e754–66.
  • Ruano-Ravina A, Pérez-Ríos M, Casàn-Clará P, et al. Low-dose CT for lung cancer screening. Lancet Oncol. 2018;19(3):e131–2.
  • Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395–409.
  • de Koning HJ, van der Aalst CM, de Jong PA, et al., Reduced lung-cancer mortality with volume CT SCREENING IN A RANDOMIZED TRIAL. N Engl J Med. 2020;382(6): 503–513.
  • Shopland DR. Tobacco use and its contribution to early cancer mortality with a special emphasis on cigarette smoking. Environ Health Perspect. 1995;103(Suppl):131–142.
  • Pérez-Ortuño R, Martínez-Sánchez JM, Fu M, et al. Assessment of tobacco specific nitrosamines (TSNAs) in oral fluid as biomarkers of cancer risk: a population-based study. Environ Res. 2016;151:635–641.
  • Hecht SS, Hoffmann D. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis. 1988;9(6):875–884.
  • Hecht SS, Stepanov I, Carmella SG. Exposure and metabolic activation biomarkers of carcinogenic tobacco-specific nitrosamines. Acc Chem Res. 2016;49(1):106–114.
  • Yuan J-M, Butler LM, Stepanov I, et al., Urinary tobacco smoke-constituent biomarkers for assessing risk of lung cancer. Cancer Res. 2014;74(2): 401–411.
  • Park EY, Lim MK, Park E, et al. Relationship between urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and lung cancer risk in the general population: a community-based prospective cohort study. Frontiers in Oncology. 2021;11:493.
  • Thomas CE, Wang R, Adams-Haduch J, et al., Urinary cotinine is as good a biomarker as serum cotinine for cigarette smoking exposure and lung cancer risk prediction. Cancer Epidemiol Biomarkers Prev. 2020;29(1): 127–132.
  • Fu M, Fernandez E, Martínez-Sánchez JM, et al. Salivary cotinine concentrations in daily smokers in Barcelona, Spain: a cross-sectional study. BMC Public Health. 2009;9(1):320.
  • Benowitz NL, Bernert JT, Foulds J, et al. Biochemical verification of tobacco use and abstinence: 2019 update. Nicotine Tob Res. 2020;22(7):1086–1097.
  • Kaaks R, Hüsing A, Fortner RT. Selecting high-risk individuals for lung cancer screening; the use of risk prediction models vs. simplified eligibility criteria. Ann Transl Med. 2017;5(20):406.
  • Tammemägi MC, Katki HA, Hocking WG, et al. Selection criteria for lung-cancer screening. N Engl J Med. 2013;368(8):728–736.
  • Volk RJ, Mendoza TR, Hoover DS, et al. Reliability of self-reported smoking history and its implications for lung cancer screening. Prev Med Reports. 2020;17:101037.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.